| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Staphylococcus aureus (methicillin-resistant) |
>0.12 |
>16 |
0.03 － >16 |
Clindamycin (Cleocin) |
604 |
| Staphylococcus aureus (methicillin-resistant) |
0.125 |
0.5 |
≤0.06 － 0.5 |
Tigecycline (GAR-936, Tigacyl) |
497 |
| Staphylococcus aureus (methicillin-resistant) |
0.13 |
0.13 |
0.06 － 0.5 |
Daptomycin (Cubicin) |
7 |
| Staphylococcus aureus (methicillin-resistant) |
0.13 |
0.25 |
? － ? |
Dalbavancin |
1111 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.25 |
0.06 － 0.5 |
Telavancin (TD-6424, Vibativ) |
73 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.25 |
0.12 － 0.25 |
Sparfloxacin (AT-4140, Zagam) |
374 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.25 |
0.12 － >32 |
Fusidic acid (Fucidin) |
604 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.25 |
? － ? |
Tigecycline (GAR-936, Tigacyl) |
444 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.5 |
0.015 － 8 |
Sitafloxacin |
12 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.5 |
0.015 － 8 |
Sitafloxacin |
1111 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.5 |
0.06 － 2 |
Daptomycin + 75 μg/ml Ca++ |
67 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.5 |
0.12 － 1 |
Tigecycline (GAR-936, Tigacyl) |
16 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.5 |
0.12 － 2 |
Fusidic acid (Fucidin) |
120 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.5 |
0.12 － 2 |
Tigecycline (GAR-936, Tigacyl) |
55 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.5 |
≤0.12 － >4 |
Quinupristin/Dalfopristin (Synercid) |
73 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.5 |
0.125 － 1 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
248 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.5 |
0.125 － 1 |
Quinupristin/Dalfopristin (Synercid) |
497 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.5 |
0.125 － 2 |
LY 191145 |
51 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.5 |
0.25 － 0.5 |
Daptomycin (Cubicin) |
16 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.5 |
0.25 － 0.5 |
Quinupristin/Dalfopristin (Synercid) |
186 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.5 |
0.25 － 0.5 |
Tigecycline (GAR-936, Tigacyl) |
89 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.5 |
≤0.25 － >8 |
Minocycline (Minocycline hydrochloride, Minocin) |
42 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
0.5 |
≤0.25 － >=16 |
Minocycline (Minocycline hydrochloride, Minocin) |
475 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
1 |
0.03 － 1 |
Quinupristin/Dalfopristin (Synercid) |
7 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
1 |
0.125 － 2 |
Chloroeremomycin (LY264826, A-82846B) |
51 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
1 |
0.125 － 8 |
Teicoplanin (Targocid) |
51 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
1 |
0.25 － 8 |
Teicoplanin (Targocid) |
16 |
| Staphylococcus aureus (methicillin-resistant) |
0.25 |
1 |
? － ? |
Minocycline (Minocycline hydrochloride, Minocin) |
36 |